Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brachytherapy | 5 | 2015 | 36 | 1.130 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 8 | 2013 | 58 | 1.020 |
Why?
|
| Radiosurgery | 5 | 2012 | 62 | 0.880 |
Why?
|
| Radiation Oncology | 4 | 2015 | 51 | 0.520 |
Why?
|
| Healthcare Failure Mode and Effect Analysis | 1 | 2015 | 2 | 0.490 |
Why?
|
| Genital Neoplasms, Female | 1 | 2015 | 17 | 0.480 |
Why?
|
| Health Physics | 3 | 2015 | 6 | 0.470 |
Why?
|
| Societies | 2 | 2015 | 24 | 0.470 |
Why?
|
| Radiotherapy | 3 | 2011 | 64 | 0.460 |
Why?
|
| Radiometry | 4 | 2011 | 36 | 0.430 |
Why?
|
| Quality Assurance, Health Care | 2 | 2015 | 253 | 0.420 |
Why?
|
| Copper | 1 | 2014 | 51 | 0.420 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2014 | 67 | 0.420 |
Why?
|
| Zinc | 1 | 2014 | 92 | 0.420 |
Why?
|
| Head and Neck Neoplasms | 1 | 2014 | 167 | 0.390 |
Why?
|
| Glossopharyngeal Nerve Diseases | 1 | 2012 | 1 | 0.390 |
Why?
|
| Microvascular Decompression Surgery | 1 | 2012 | 1 | 0.390 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2009 | 67 | 0.370 |
Why?
|
| Physics | 1 | 2011 | 12 | 0.350 |
Why?
|
| Research Report | 1 | 2011 | 26 | 0.350 |
Why?
|
| Information Management | 1 | 2009 | 12 | 0.320 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 414 | 0.310 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2013 | 1594 | 0.300 |
Why?
|
| Health Services Needs and Demand | 1 | 2009 | 207 | 0.290 |
Why?
|
| Meningeal Neoplasms | 1 | 2008 | 59 | 0.290 |
Why?
|
| Meningioma | 1 | 2008 | 60 | 0.290 |
Why?
|
| Radiotherapy, Conformal | 2 | 2006 | 19 | 0.280 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2013 | 140 | 0.280 |
Why?
|
| Radiotherapy Dosage | 6 | 2013 | 84 | 0.240 |
Why?
|
| Brain Neoplasms | 1 | 2008 | 308 | 0.230 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2009 | 755 | 0.220 |
Why?
|
| Film Dosimetry | 1 | 2004 | 9 | 0.220 |
Why?
|
| Checklist | 2 | 2015 | 73 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 2154 | 0.180 |
Why?
|
| Phantoms, Imaging | 3 | 2012 | 224 | 0.160 |
Why?
|
| Radiotherapy, Intensity-Modulated | 2 | 2008 | 35 | 0.150 |
Why?
|
| Humans | 19 | 2015 | 62966 | 0.140 |
Why?
|
| Radiotherapy, High-Energy | 2 | 2013 | 7 | 0.130 |
Why?
|
| Rectum | 2 | 2013 | 88 | 0.120 |
Why?
|
| Radiotherapy, Image-Guided | 2 | 2012 | 8 | 0.120 |
Why?
|
| Research Design | 2 | 2011 | 573 | 0.120 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2013 | 287 | 0.110 |
Why?
|
| Skin | 2 | 2007 | 377 | 0.110 |
Why?
|
| Monte Carlo Method | 2 | 2012 | 90 | 0.110 |
Why?
|
| Safety Management | 1 | 2015 | 137 | 0.110 |
Why?
|
| Algorithms | 2 | 2011 | 1003 | 0.110 |
Why?
|
| Treatment Outcome | 4 | 2013 | 5608 | 0.100 |
Why?
|
| Follow-Up Studies | 4 | 2013 | 2450 | 0.100 |
Why?
|
| Dose-Response Relationship, Radiation | 3 | 2013 | 52 | 0.100 |
Why?
|
| Body Mass Index | 2 | 2013 | 864 | 0.100 |
Why?
|
| Lymph Nodes | 1 | 2013 | 223 | 0.100 |
Why?
|
| Patient Safety | 1 | 2015 | 242 | 0.100 |
Why?
|
| Rotation | 1 | 2012 | 23 | 0.100 |
Why?
|
| Radiotherapy Setup Errors | 1 | 2011 | 2 | 0.100 |
Why?
|
| Immobilization | 1 | 2011 | 13 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2013 | 97 | 0.090 |
Why?
|
| Precision Medicine | 1 | 2012 | 119 | 0.090 |
Why?
|
| Computers | 1 | 2011 | 49 | 0.090 |
Why?
|
| Pain Measurement | 1 | 2012 | 343 | 0.090 |
Why?
|
| Movement | 1 | 2011 | 155 | 0.090 |
Why?
|
| Quality Control | 1 | 2011 | 74 | 0.090 |
Why?
|
| Biopsy | 3 | 2007 | 431 | 0.090 |
Why?
|
| Breast | 1 | 2012 | 183 | 0.090 |
Why?
|
| Recurrence | 1 | 2012 | 638 | 0.080 |
Why?
|
| Patient Positioning | 1 | 2010 | 48 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 163 | 0.080 |
Why?
|
| Photons | 2 | 2012 | 25 | 0.080 |
Why?
|
| Particle Accelerators | 1 | 2008 | 6 | 0.080 |
Why?
|
| Oncology Service, Hospital | 1 | 2008 | 3 | 0.080 |
Why?
|
| Trigeminal Neuralgia | 1 | 2008 | 8 | 0.070 |
Why?
|
| Neuroma, Acoustic | 1 | 2008 | 13 | 0.070 |
Why?
|
| Surgery Department, Hospital | 1 | 2008 | 21 | 0.070 |
Why?
|
| Linear Energy Transfer | 1 | 2007 | 3 | 0.070 |
Why?
|
| California | 1 | 2008 | 174 | 0.070 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2008 | 70 | 0.070 |
Why?
|
| Neoplasm Staging | 3 | 2013 | 490 | 0.070 |
Why?
|
| Models, Theoretical | 1 | 2009 | 271 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2011 | 440 | 0.070 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2006 | 3 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 1644 | 0.060 |
Why?
|
| Biochemistry | 1 | 2006 | 50 | 0.060 |
Why?
|
| Aged | 4 | 2014 | 14300 | 0.060 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2005 | 12 | 0.060 |
Why?
|
| Genome, Human | 1 | 2007 | 239 | 0.060 |
Why?
|
| Middle Aged | 5 | 2013 | 17430 | 0.060 |
Why?
|
| Societies, Scientific | 1 | 2005 | 36 | 0.060 |
Why?
|
| Equipment Failure Analysis | 1 | 2005 | 75 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 660 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2009 | 588 | 0.060 |
Why?
|
| X-Ray Film | 1 | 2004 | 1 | 0.060 |
Why?
|
| Ions | 1 | 2004 | 56 | 0.050 |
Why?
|
| Female | 6 | 2015 | 32620 | 0.050 |
Why?
|
| Radiation Dosage | 3 | 2013 | 134 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 876 | 0.050 |
Why?
|
| Male | 3 | 2014 | 29620 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 1195 | 0.050 |
Why?
|
| RNA | 1 | 2006 | 422 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2006 | 404 | 0.050 |
Why?
|
| United States | 2 | 2015 | 7756 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 728 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 1141 | 0.040 |
Why?
|
| Proteins | 1 | 2006 | 751 | 0.040 |
Why?
|
| Models, Biological | 1 | 2006 | 1183 | 0.040 |
Why?
|
| Adult | 4 | 2013 | 16693 | 0.030 |
Why?
|
| Documentation | 1 | 2015 | 127 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2013 | 83 | 0.030 |
Why?
|
| Pelvis | 1 | 2013 | 58 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 5424 | 0.030 |
Why?
|
| Scattering, Radiation | 1 | 2012 | 74 | 0.020 |
Why?
|
| Calibration | 1 | 2011 | 67 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2013 | 6565 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 377 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2012 | 563 | 0.020 |
Why?
|
| Mammography | 1 | 2012 | 280 | 0.020 |
Why?
|
| Prognosis | 1 | 2013 | 1734 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 298 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2007 | 375 | 0.020 |
Why?
|
| Relative Biological Effectiveness | 1 | 2006 | 7 | 0.020 |
Why?
|
| Body Burden | 1 | 2006 | 12 | 0.020 |
Why?
|
| Radiation, Ionizing | 1 | 2006 | 15 | 0.020 |
Why?
|
| Benchmarking | 1 | 2006 | 135 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2006 | 478 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 3755 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2006 | 2055 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2007 | 3027 | 0.010 |
Why?
|
| Risk Factors | 1 | 2006 | 5318 | 0.010 |
Why?
|